Avacincaptad Pegol Sodium
A pegylated RNA aptamer that binds and inhibits complement component C5, blocking a branch of the complement system that drives the destruction of retinal cells in geographic atrophy. It is administered by intravitreal injection.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
HBD / HBA
- / -
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Sıkça Sorulan Sorular
A pegylated RNA aptamer that binds and inhibits complement component C5, blocking a branch of the complement system that drives the destruction of retinal cells in geographic atrophy. It is administered by intravitreal injection.
Yes, Avacincaptad Pegol Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4297889. Open-access bioactivity database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="avacincaptad-pegol-sodium"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/avacincaptad-pegol-sodium/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/avacincaptad-pegol-sodium/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/avacincaptad-pegol-sodium/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="avacincaptad-pegol-sodium"></drugfyi-drug>